Johns Hopkins scientists identify how gut bacterium triggers colorectal cancer
A toxin produced by Bacteroides fragilis damages the colon's protective lining and drives chronic inflammation, providing a long-sought mechanistic link to tumour formation.
Researchers at Johns Hopkins have published findings that resolve a two-decade puzzle about how the common gut bacterium Bacteroides fragilis contributes to colorectal cancer. The work identifies a toxin produced by certain strains of B. fragilis — known as fragilysin or BFT — as the critical intermediary: the toxin disrupts the epithelial barrier lining the colon, triggers sustained inflammatory signalling, and creates conditions that promote tumour development.
Colorectal cancer is one of the most prevalent cancers globally, and microbial contributions to its aetiology have been an active area of investigation. The enterotoxigenic strain of B. fragilis (ETBF) has been a candidate for many years, but the precise sequence of events linking bacterial colonisation to malignancy had remained incompletely characterised. The Johns Hopkins team's findings, reported via ScienceDaily, describe how barrier disruption and inflammatory cascades downstream of toxin exposure converge on pro-tumourigenic pathways.
The full publication details, including journal, lead author, and peer-review status, were not available in the feed summary. Readers seeking methodological detail should consult the primary journal article. This is an educational summary based on public reporting; the findings represent a research advance in cancer biology and do not alter current screening or clinical management guidance.
Plain-language version
For patients, families, and general readers. Educational only — not medical advice.
Researchers at Johns Hopkins have found an important clue about how a common gut bacterium called Bacteroides fragilis may help cause bowel cancer. A protein released by certain forms of this bacterium appears to damage the protective lining of the colon, cause long-lasting inflammation, and set the stage for tumours to form. Scientists have suspected this bacterium might be involved in bowel cancer for about 20 years, but this work helps explain how the process might actually happen. The research is at an early stage and does not change how bowel cancer is currently diagnosed or treated. This is an educational summary, not medical advice. If anything here raises questions for you, please speak with your GP or a clinical professional.
Sources
Read the original reporting — these are the public sources this summary draws from.
-
Primary source ScienceDaily · 2026-10-31Scientists finally discover how a common gut bacterium can trigger colon cancer